⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for unresectable advanced renal cell carcinoma

Every month we try and update this database with for unresectable advanced renal cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)NCT02454478
Carcinoma, Rena...
Lenvatinib
Everolimus
20 Years - Eisai Inc.
Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCCNCT04413123
Papillary Renal...
Unclassified Re...
Translocation R...
Chromophobe Ren...
Collecting Duct...
Renal Cell Carc...
Unresectable Ad...
Metastatic Ncc ...
Cabozantinib
Nivolumab
Ipilimumab
18 Years - Dana-Farber Cancer Institute
Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCCNCT04413123
Papillary Renal...
Unclassified Re...
Translocation R...
Chromophobe Ren...
Collecting Duct...
Renal Cell Carc...
Unresectable Ad...
Metastatic Ncc ...
Cabozantinib
Nivolumab
Ipilimumab
18 Years - Dana-Farber Cancer Institute
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: